These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26598040)

  • 1. Validation of the Modified Glasgow Prognostic Score in Advanced Cancer Patients Receiving Palliative Care.
    Pantano Nde P; Paiva BS; Hui D; Paiva CE
    J Pain Symptom Manage; 2016 Feb; 51(2):270-7. PubMed ID: 26598040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system.
    Laird BJ; Kaasa S; McMillan DC; Fallon MT; Hjermstad MJ; Fayers P; Klepstad P
    Clin Cancer Res; 2013 Oct; 19(19):5456-64. PubMed ID: 23938289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
    Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
    Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
    Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
    Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of nutritional status and inflammation with survival in patients with advanced cancer in palliative care.
    Souza Cunha M; Wiegert EVM; Calixto-Lima L; Oliveira LC
    Nutrition; 2018; 51-52():98-103. PubMed ID: 29625409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative stenting for oesophagogastric cancer: tumour and host factors and prognosis.
    Park JH; Woodley N; McMillan DC; Glen P
    BMJ Support Palliat Care; 2019 Sep; 9(3):332-339. PubMed ID: 29574423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
    Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
    Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
    J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostication in advanced cancer: a study examining an inflammation-based score.
    Partridge M; Fallon M; Bray C; McMillan D; Brown D; Laird B
    J Pain Symptom Manage; 2012 Aug; 44(2):161-7. PubMed ID: 22732417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.
    Leung EY; Scott HR; McMillan DC
    J Thorac Oncol; 2012 Apr; 7(4):655-62. PubMed ID: 22425914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
    Roncolato FT; Berton-Rigaud D; O'Connell R; Lanceley A; Sehouli J; Buizen L; Okamoto A; Aotani E; Lorusso D; Donnellan P; Oza A; Avall-Lundqvist E; Berek J; Hilpert F; Ledermann JA; Kaminsky MC; Stockler MR; King MT; Friedlander M
    Gynecol Oncol; 2018 Jan; 148(1):36-41. PubMed ID: 29107348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study.
    Imaoka H; Mizuno N; Hara K; Hijioka S; Tajika M; Tanaka T; Ishihara M; Yogi T; Tsutsumi H; Fujiyoshi T; Sato T; Shimizu Y; Niwa Y; Yamao K
    Pancreas; 2016 Feb; 45(2):211-7. PubMed ID: 26495775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non-small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores.
    McGovern J; O'Rourke F; Will S; Nguyen HTN; Cranfield E; Maseland C; MacLeod N; Maclay JD; Laird BJ; Dolan RD; McMillan DC
    Cancer Med; 2024 Aug; 13(16):e70139. PubMed ID: 39164973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.
    Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR
    Oncology; 2012; 83(5):292-9. PubMed ID: 22964877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic risk stratification using C-reactive protein, albumin, and associated inflammatory biomarkers in patients with advanced cancer in palliative care.
    Silva GAD; Oliveira LC; Wiegert EVM; Calixto-Lima L; Cunha GDC; Peres WAF
    Curr Probl Cancer; 2024 Aug; 51():101115. PubMed ID: 38943779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
    Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment.
    Alan O; Telli TA; Basoğlu T; Arikan R; Demircan NC; Ercelep O; Bozkurt S; Atasoy BM; Dane F; Yumuk PF
    Clin Neurol Neurosurg; 2020 Sep; 196():105976. PubMed ID: 32531614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.